Pediatrics, Perinatology and Child Health; Hematology; Oncology
Disciplines :
Pediatrics
Author, co-author :
Geurten, Claire ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pédiatrie ; Department of Paediatric Haematology/Oncology, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK
Errington, Julie; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle upon Tyne, UK
Barnett, Shelby; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle upon Tyne, UK
Patel, Hiten; Department of Paediatric Radiology, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK
Noor, Saqib; Department of Paediatric Orthopaedic Surgery, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK
Saraff, Vrinda; Department of Paediatric Endocrinology, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK
Veal, Gareth J; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle upon Tyne, UK
Gatz, Susanne A; Department of Paediatric Haematology/Oncology, Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK ; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Language :
English
Title :
Spontaneous fractures during 13-cis retinoic acid therapy for neuroblastoma.
This work was supported in part by Cancer Research UK, the Experimental Cancer Medicine Centre Network, the National institute for Health Research and the Little Princess Trust.
Steliarova-Foucher E, Colombet M, Ries L, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet North Am Ed. 2017;18:719-731.
Smith V, Foster J. High-risk neuroblastoma treatment review. Children. 2018;5:114.
Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst. 1982;68(4):589-596.
Reynolds CP, Kane DJ, Einhorn PA, et al. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res. 1991;366:203-211.
Villablanca JG, Khan AA, Avramis VI, et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol. 1995;13:894-901.
Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341(16):1165-1173.
Veal GJ, Errington J, Rowbotham SE, et al. Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma. Clin Cancer Res. 2013;19(2):469-479.
Simon T, Hero B, Schulte J, et al. 2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors. Klin Padiatr. 2017;229:147-167.
Ladenstein R. High-risk neuroblastoma study 1.5 of SIOP-Europe (SIOPEN). International Society of Pediatric Oncology European Neuroblastoma High Risk; 2014:132-134.
Veal GJ, Tweddle DA, Visser J, et al. Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: a randomized crossover clinical trial. Cancers. 2021;13(8):1868.
Khan AA, Villablanca JG, Reynolds CP, et al. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother Pharmacol. 1996;39:34-41.
Veal GJ, Cole M, Errington J, et al. Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - study of the United Kingdom Children's Cancer Study Group. Br J Cancer. 2007;96(3):424-431.
Miziołek B, Bergler-Czop B, Stańkowska A, Brzezińska-Wcisło L. The safety of isotretinoin treatment in patients with bone fractures. Adv Dermatol Allergol. 2019;36:18-24.
Hotchkiss CE, Latendresse J, Ferguson SA. Oral treatment with retinoic acid de-creases bone mass in rats. Comp Med. 2006;56:502-511.
Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287:47-54.
Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. 2003;348:287-294.
Mata-Granados JM, Cuenca-Acevedo JR, Luque de Castro MD, et al. Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women. Arch Osteoporos. 2013;8:124.
Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, et al. Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. Am J Clin Nutr. 2009;89:323-330.
Koh K-N, Jeon JY, Park S-S, et al. Physeal abnormalities in children with high-risk neuroblastoma intensively treated with/without 13-cis-retinoic acid. J Pediatr Orthop. 2021;41(9):e841-e848.
